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Introduction
• OSA is a significant risk factor for T2DM
– OSA alters glucose metabolism and promotes insulin resistance
• CPAP treatment can potentially improve glycemic control in 
those with T2DM 
– However, exact effects of CPAP treatment on diabetes are uncertain
– Some studies report a significant reduction in HbA1c levels after CPAP 
treatment, while other studies report no significant change 
• Study limitations include small sample sizes and varying CPAP 
compliance among subjects
• Our project will be able to address these problems
– Sample size of 2000-5000 subjects





– What is the effect of CPAP treatment on HbA1c 
and blood glucose levels in subjects with 
moderate to severe OSA with and without T2DM?
• Hypothesis
– In moderate to severe OSA subjects with and 
without T2DM, CPAP treatment will significantly 
reduce HbA1c and blood glucose levels
Approach & Results
• Study Design: Combined retrospective and prospective 
study
• Population/Study Sample: Moderate to severe OSA 
subjects with and without T2DM
• Intervention: CPAP treatment
• Comparison groups: No CPAP/Non-adherence
• Outcome variable: HbA1c and blood glucose levels
• Data source and collection: EPIC medical record review
Approach & Results
• Analysis 
– Compare HbA1c and blood glucose levels before and after CPAP treatment in 
moderate to severe OSA subjects with and without T2DM (experimental 
group)
– Compare HbA1c and blood glucose levels in moderate to severe OSA subjects 
with no CPAP treatment or non-adherence (control group)
• Findings
– Looked at changes in blood glucose levels from before to after CPAP 
treatment
• Compared to control group (No CPAP Treatment)
– Due to low sample size, only blood glucose levels were analyzed as none of 
these subjects had HbA1c levels in their medical records
Approach & Results
*Values in parentheses represent sample size for each subgroup
Conclusions
• There was a decrease in blood glucose levels in 
subjects that underwent CPAP treatment 
compared to those who did not
– Not significant due to low sample size
• In current literature, the exact effects of CPAP 
treatment on glycemic control in OSA subjects is 
uncertain
– With more collected data, our study may shed some 
light on this matter
– If our hypothesis is proven to be true, CPAP therapy 
may be a viable treatment strategy for improving 
glycemic control in patients with and without T2DM
Future Directions
• Complete data collection for the remainder of 
the sample size and analyze data
• Prospective follow up on available subjects to 
determine long term effects on glycemic 
control
• Planned journal publications
• Planned research conference presentations
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